Amoxicillin - Generic Drug Details

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What are the generic sources for amoxicillin and what is the scope of patent protection?

Amoxicillin is the generic ingredient in twenty-five branded drugs marketed by Aurobindo, Chartwell, Hikma Pharms, Labs Atral, Micro Labs, Mylan, Sandoz, Strides Pharma, Sun Pharm Inds Ltd, Teva, Glaxosmithkline, Us Antibiotics, Apothecon, Parke Davis, Wyeth Ayerst, Aurobindo Pharma Ltd, Belcher Pharms, Dava Pharms Inc, Hikma, Wockhardt Bio Ag, Pragma, Ranbaxy Labs Ltd, Ani Pharms, Rising, Sandoz Inc, Takeda Pharms Usa, Cumberland Pharms, Phathom, Aurobindo Pharma, Micro Labs Ltd India, Apotex Inc, Teva Pharms Usa, and Redhill, and is included in one hundred and twenty NDAs. There are ten patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Amoxicillin has eleven patent family members in six countries.

There are forty-six drug master file entries for amoxicillin. Thirty suppliers are listed for this compound.

Summary for amoxicillin

International Patents:	11
US Patents:	10
Tradenames:	25
Applicants:	33
NDAs:	120
Drug Master File Entries:	46
Finished Product Suppliers / Packagers:	30
Raw Ingredient (Bulk) Api Vendors:	62
Clinical Trials:	528
Patent Applications:	5,493
Formulation / Manufacturing:	see details
Drug Prices:	Drug price trends for amoxicillin
Drug Sales Revenues:	Drug sales revenues for amoxicillin
What excipients (inactive ingredients) are in amoxicillin?	amoxicillin excipients list
DailyMed Link:	amoxicillin at DailyMed

See drug prices for amoxicillin

Drug Sales Revenue Trends for amoxicillin

See drug sales revenues for amoxicillin

Recent Clinical Trials for amoxicillin

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Kaizen Bioscience Co.	Phase 1
Liaocheng People's Hospital	Phase 1
The Taimaka Project	Phase 3

See all amoxicillin clinical trials

Pharmacology for amoxicillin

Drug Class	Penicillin-class Antibacterial beta Lactamase Inhibitor
Mechanism of Action	beta Lactamase Inhibitors

Medical Subject Heading (MeSH) Categories for amoxicillin

Anti-Bacterial Agents

US Patents and Regulatory Information for amoxicillin

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Aurobindo Pharma Ltd	AMOXICILLIN	amoxicillin	TABLET, FOR SUSPENSION;ORAL	065324-002	Jan 17, 2007		DISCN	No	No	See Plans and Pricing	See Plans and Pricing				See Plans and Pricing
Teva	AMOXICILLIN	amoxicillin	TABLET, CHEWABLE;ORAL	064031-001	Dec 19, 1996		DISCN	No	No	See Plans and Pricing	See Plans and Pricing				See Plans and Pricing
Cumberland Pharms	OMEPRAZOLE AND CLARITHROMYCIN AND AMOXICILLIN	amoxicillin; clarithromycin; omeprazole	CAPSULE, TABLET, CAPSULE, DELAYED RELEASE;ORAL	050824-001	Feb 8, 2011		DISCN	Yes	No	See Plans and Pricing	See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for amoxicillin

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pragma	MOXATAG	amoxicillin	TABLET, EXTENDED RELEASE;ORAL	050813-001	Jan 23, 2008	See Plans and Pricing	See Plans and Pricing
Pragma	MOXATAG	amoxicillin	TABLET, EXTENDED RELEASE;ORAL	050813-001	Jan 23, 2008	See Plans and Pricing	See Plans and Pricing
Pragma	MOXATAG	amoxicillin	TABLET, EXTENDED RELEASE;ORAL	050813-001	Jan 23, 2008	See Plans and Pricing	See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for amoxicillin

Subscribe to access the full database, or Try it Free
Country	Patent Number	Title	Estimated Expiration
Australia	2006321782	Pharmaceutical compositions and methods for improved bacterial eradication	See Plans and Pricing
European Patent Office	1968586	COMPOSITIONS PHARMACEUTIQUES ET MÉTHODES POUR ÉRADICATION BACTÉRIENNE AMÉLIORÉE (PHARMACEUTICAL COMPOSITIONS AND METHODS FOR IMPROVED BACTERIAL ERADICATION)	See Plans and Pricing
European Patent Office	1969134	PRODUITS D'AMOXICILLINE À LIBÉRATION MODIFIÉE (MODIFIED RELEASE AMOXICILLIN PRODUCTS)	See Plans and Pricing
>Country	>Patent Number	>Title	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.